MedChemComm themed issue: Chemical Biology for Target Identification and Validation
Guest Editors: Nathanael Gray (Harvard University, USA) and Lyn Jones (Pfizer, Cambridge, USA)
Submission Deadline: 30th September 2013
Submissions are now open for a high-profile themed issue on Chemical Biology for Target Identification and Validation, due for publication in MedChemComm in early 2014. It will receive great exposure and significant promotion.
Scope
Part of MedChemComm’s mission is to publish high level chemistry biology research which enables drug discovery. This special issue will be broad in scope, covering advances in the discovery, development and application of chemical biology to elucidate and validate new therapeutic targets. Relevant topics include (but are not limited to):
- the use of –omics and imaging technologies
- immunoprecipitation and affinity chromatography to identify novel targets and therapeutic modalities
- the creation and development of new techniques to assess target (and off-target) engagement
- advances in areas such as chemogenomics, microarrays, yeast three hybrid, RNAi and chem/bioinformatics
New research in MedChemComm is published as Concise Articles. This article type encompasses both Communication and Full Paper styles and is generally between 3 and 7 pages in length, but there is no strict page limit.
Manuscripts can be submitted in any reasonable format using our submission system. Template is not required. Please indicate that it is for the Chemical Biology themed issue in the comments to the editor field. The level of quality of this issue will be high, and all manuscripts will undergo the journal’s normal peer review process.
The deadline for submissions to the themed issue is 30th September 2013, although submissions before this date are of course welcomed.
